The latest myeloma news
Response to COVID-19 vaccines varies widely in blood cancer patients
Patients with multiple myeloma had a widely variable response to COVID-19 vaccines—in some cases, no…
Browsing: Myeloma
Researchers study potential new CAR-T cell therapy for multiple myeloma
Researchers at Mayo Clinic Cancer Center, USA, are studying a potential new chimeric antigen receptor-T…
EHA 2021: Overall survival benefit established with daratumumab plus lenalidomide and dexamethasone in elderly patients with transplant-ineligible newly diagnosed multiple myeloma
The phase 3 MAIA study evaluated D-Rd versus Rd in 737 patients who were ineligible…
EHA 2021: Daratumumab maintenance improves progression-free survival after autologous stem cell transplantation in multiple myeloma patients
Part 1 of the CASSIOPEIA phase-3 study compared the addition of daratumumab to bortezomib, thalidomide,…
New therapy shoes promise in future treatment of multiple myeloma
A preclinical study has found multiple myeloma is highly sensitive to a newly developed experimental…
New epigenetic regulatory mechanisms involved in multiple myeloma growth
An international team of researchers from Japan, the US and the UK has analyzed the…
European commission approves second indication of isatuximab for relapsed multiple myeloma
Today, the European Commission (EC) approved isatuximab in combination with carfilzomib and dexamethasone (Kd) for…
First Covid jab provides protection for most myeloma blood cancer patients
A single dose of a Covid-19 vaccine triggers an immune response in around 70 per…
One drop of blood brings progression of multiple myeloma into better view
A new method makes it much easier to follow the progression of multiple myeloma, a…
Multiple myeloma: CAR T-cell therapy generates lasting remissions
In a major advance in the treatment of multiple myeloma, a CAR T-cell therapy has…